Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global Bio-chem Technology Group Co's earnings before interest and taxes (EBIT) for the
six
months ended in Dec. 2025 was HK$432 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$465 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Global Bio-chem Technology Group Co's annualizedROC % for the quarter that ended in Dec. 2025 was -4.20%.
Global Bio-chem Technology Group Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 36.09%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Global Bio-chem Technology Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 11.36%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Bio-chem Technology Group Co EBIT Related Terms
Global Bio-chem Technology Group Co EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Global Bio-chem Technology Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Bio-chem Technology Group Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Global Bio-chem Technology Group Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Global Bio-chem Technology Group Co's EV-to-EBIT falls into.
Global Bio-chem Technology Group Co EBIT Calculation
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$465 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Bio-chem Technology Group Co (HKSE:00809) has a EBIT of HK$465 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Global Bio-chem Technology Group Co.
Is Global Bio-chem Technology Group Co's EBIT too high?
Global Bio-chem Technology Group Co's current EBIT is HK$465 Mil. Overall, Global Bio-chem Technology Group Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Global Bio-chem Technology Group Co's EBIT compare to KHC and GIS?
Global Bio-chem Technology Group Co's EBIT of HK$465 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Global Bio-chem Technology Group Co. Global Bio-chem Technology Group Co's current EBIT is HK$465 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Bio-chem Technology Group Co stock overvalued right now?
Global Bio-chem Technology Group Co (HKSE:00809) has a current EBIT of HK$465 Mil. The current EBIT is HK$465 Mil. Global Bio-chem Technology Group Co's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Global Bio-chem Technology Group Co (HKSE:00809), the current EBIT is HK$465 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Global Bio-chem Technology Group Co Ltd is engaged in the manufacture and sale of corn refined products and amino acids. The upstream corn refinery serves as a feedstock which breaks down corn kernels into corn starch, gluten meal, fibre and corn oil; and corn starch is further refined through a series of biochemical and/or chemical processes into a wide range of high value-added downstream products. Its segments include the upstream products segment; and the amino acids segment engages in the manufacture and sale of corn based biochemical products, including lysine and threonine. It derives the majority of the revenue from the amino acids segment. Geographically, it operates in The PRC, and Asia, the Americas and other regions.
33GF Score
Get the complete analysis for HKSE:00809
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00809 has been successfully added to your 
